Del Carmen Jeffrey, an insider at Catalyst Pharmaceuticals Inc (CPRX), executed a sale of 3,962 shares on November 25, 2025, at a price of $23.33 per share, totaling approximately $92,000. Following this transaction, Jeffrey retains 3,962 shares in the company.
Catalyst Pharmaceuticals, a commercial-stage biopharmaceutical firm based in Coral Gables, Florida, focuses on developing and marketing innovative medicines for patients with rare diseases. The company currently has a market capitalization of $2.9 billion and a P/E ratio of 13.36, with earnings per share (EPS) reported at 1.72.
Insider selling can occur for various reasons, including diversification or personal financial needs. While such activity can attract attention, it does not inherently reflect negative sentiment towards the company. Investors are advised to consider insider transactions as one of many factors in their analysis, rather than relying on isolated trades.
Catalyst Pharmaceuticals is preparing for upcoming earnings reports, with estimates of $0.65 EPS and $152.6 million in revenue expected on August 4, 2026, following an anticipated $0.62 EPS and $145.2 million in revenue on May 5, 2026. These figures provide additional context for evaluating the company's performance amidst insider trading activities.